bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies is developing diagnostics based on its proprietary platform for use with BAL fluid to detect lung cancer and to detect COPD.